stockrowAdcare Health Systems Inc
RHEP Healthcare Medical Care Facilities
Adcare Health Systems Inc’s revenue for fiscal 2025 (year ended December 2025) was $53.2 million, up 189.9% from fiscal 2024.
- Revenue
- +143.0%
- EPS
- +70.6%
- Free cash flow
- +224.5%
- Total debt
- −13.0%
Quarter to June 2026, against a year earlier
Follow RHEP
Alert me
Adcare Health Systems Inc (RHEP) EV/Sales
As of 6 November 2026, Adcare Health Systems Inc (RHEP) trades at a EV/Sales of 0.5×. Over the past ten years it has ranged from 0.5× (September 2026) to 14.6× (July 2015); the current reading is higher than 0% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.8× | (71.05%) |
| FY2024 | 2.7× | 8.45% |
| FY2023 | 2.5× | 61.46% |
| FY2022 | 1.6× | (29.48%) |
| FY2021 | 2.2× | (36.70%) |
| FY2020 | 3.5× | 41.81% |
| FY2019 | 2.5× | (31.05%) |
| FY2018 | 3.6× | 33.25% |
| FY2017 | 2.7× | (18.81%) |
| FY2016 | 3.3× | (44.26%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.5× | (21.01%) |
| Mar 2026 | 0.7× | (15.48%) |
| Dec 2025 | 0.8× | (50.43%) |
| Sep 2025 | 1.6× | (29.19%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| DCGO DocGo Inc. compare | 0.0× |
| NVOS Novo Integrated Sciences, Inc. compare | 0.0× |
| PIII P3 Health Partners Inc. compare | 0.1× |
| RHEP Adcare Health Systems Inc | 0.5× |
| BTMD biote Corp. compare | 0.8× |
| AMS American Shared Hospital Services compare | 0.9× |
| SYRA Syra Health Corp. compare | 1.2× |
| CCEL Cryo-Cell International Inc. compare | 1.5× |
| CCM Concord Medical Services Holdings Limited compare | 2.6× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)